Sattva Pharmaceuticals Private Limited
About Sattva Pharmaceuticals Private Limited
Data last updated:
Sattva Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Apostolos Pharmaceuticals Pvt Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 January 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1984PTC031774.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandra Shyam Ruia and Shyam Madanmohan Ruia.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹50,000, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹15,165 (net margin 30.3%) and EBITDA of ₹21,165 (EBITDA margin 42.3%). Revenue has grown at a compounded annual rate (CAGR) of 71% over three years and 33% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sattva Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressB – 714 Floor – 7th B Wing Plaza Panchashil Nyaymurti Sitaram Patkar Marg Grant Roa, D, Mumbai, Maharashtra, India – 400007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sattva Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sattva Pharmaceuticals is financial and insurance activities. In detail, this covers activities auxiliary to financial service and insurance activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| K | Financial and insurance activities | 66 | Activities auxiliary to financial service and insurance activities |
To see the full business activity and turnover split of Sattva Pharmaceuticals Private Limited, buy the company report.
Financials of Sattva Pharmaceuticals Private Limited
FY 2025 filings availableSattva Pharmaceuticals Private Limited reported revenue of ₹50,000 (down 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 29% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 33%. EBITDA fell 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21,165 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15,165 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 42.3% | ||||
| Net Profit Margin | 30.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sattva Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sattva Pharmaceuticals Private Limited
Sattva Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandra Shyam Ruia | Director | 10 Aug 2018 | 8 Years 2 Months | Current |
| Shyam Madanmohan Ruia | Director | 10 Aug 2018 | 8 Years 2 Months | Current |
Auditor
Sattva Pharmaceuticals Private Limited is audited by D Y & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D Y & ASSOCIATES | FY 2021 | 141274W |
Shareholding
The shareholding of Sattva Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Sattva Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sattva Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sattva Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sattva Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sattva Pharmaceuticals Private Limited has 7 board changes on record since 2012: 2 appointments and 5 cessations. The latest: Chandra Shyam Ruia ceased to be Additional Director on 28 Sep 2019.
Frequently asked questions
Sattva Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 January 1984 (42+ years old) and is registered under CIN U24230MH1984PTC031774.
Sattva Pharmaceuticals has 2 current directors:
- Chandra Shyam Ruia - Director
- Shyam Madanmohan Ruia - Director
The latest financial statements of Sattva Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Sattva Pharmaceuticals is U24230MH1984PTC031774. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sattva Pharmaceuticals was incorporated on 07 January 1984, making it 42+ years old. It is registered with the Registrar of Companies, Mumbai.
Chandra Shyam Ruia ceased to be Additional Director on 28 Sep 2019. Shyam Madanmohan Ruia ceased to be Additional Director on 28 Sep 2019. Ashok Mahadeo Shinde ceased to be Director on 11 Aug 2018. Sattva Pharmaceuticals has 7 board changes on record in total.
The registered office of Sattva Pharmaceuticals is at B – 714 Floor – 7th B Wing Plaza Panchashil Nyaymurti Sitaram Patkar Marg Grant Roa, D, Mumbai, Maharashtra, India – 400007.
Sattva Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Sattva Pharmaceuticals is compliant as of 15 September 2026. The company is actively filing with the Registrar of Companies.
Sattva Pharmaceuticals can be reached at its registered office: B – 714 Floor – 7th B Wing Plaza Panchashil Nyaymurti Sitaram Patkar Marg Grant Roa, D, Mumbai, Maharashtra, India – 400007.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
